Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Minimal residual disease is a...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Minimal residual disease is a significant predictor of treatment failure in B lineage adult ALL: final results of the international trial UKALL XII:ECOG 2993
Bibliographic Details
Main Authors:
Patel, B
,
Buck, G
,
Mortuza, Y
,
Rai, L
,
Mitchell, W
,
Gerrard, G
,
Hoffbrand, A
,
Goldstone, A
,
Foroni, L
Format:
Journal article
Published:
2009
Holdings
Description
Similar Items
Staff View
Similar Items
Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993.
by: Patel, B, et al.
Published: (2010)
The outcome of 551 1(st) CR transplants in adult ALL from the UKALL XII/ECOG 2993 study
by: Goldstone, A, et al.
Published: (2004)
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.
by: Sive, J, et al.
Published: (2012)
The impact of imatinib therapy on adult Philadelphia positive acute lymphoblastic leukaemia (ALL): Early results from the UKALL12/ECOG 2993 study
by: Patel, B, et al.
Published: (2005)
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993.
by: Lazarus, H, et al.
Published: (2006)